Rank | Gene Set | Z-score |
---|---|---|
1 | angiotensin maturation (GO:0002003) | 7.37027583 |
2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.02250790 |
3 | epoxygenase P450 pathway (GO:0019373) | 6.66767884 |
4 | regulation of bile acid biosynthetic process (GO:0070857) | 5.77090211 |
5 | intestinal absorption (GO:0050892) | 5.53854026 |
6 | cellular glucuronidation (GO:0052695) | 5.46080047 |
7 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.25783447 |
8 | lipoprotein transport (GO:0042953) | 5.23878190 |
9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.18947070 |
10 | glucuronate metabolic process (GO:0019585) | 5.16094257 |
11 | uronic acid metabolic process (GO:0006063) | 5.16094257 |
12 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.07446574 |
13 | hormone catabolic process (GO:0042447) | 5.02564576 |
14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.93805886 |
15 | drug metabolic process (GO:0017144) | 4.90569720 |
16 | NADH metabolic process (GO:0006734) | 4.71964833 |
17 | urea metabolic process (GO:0019627) | 4.65384168 |
18 | bile acid and bile salt transport (GO:0015721) | 4.65245667 |
19 | * drug transmembrane transport (GO:0006855) | 4.58515291 |
20 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.55381167 |
21 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.55381167 |
22 | endocrine process (GO:0050886) | 4.55381167 |
23 | regulation of cholesterol esterification (GO:0010872) | 4.53641200 |
24 | exogenous drug catabolic process (GO:0042738) | 4.48925983 |
25 | urea cycle (GO:0000050) | 4.48215768 |
26 | regulation of guanylate cyclase activity (GO:0031282) | 4.47287081 |
27 | drug catabolic process (GO:0042737) | 4.46937973 |
28 | regulation of triglyceride catabolic process (GO:0010896) | 4.44251717 |
29 | diacylglycerol metabolic process (GO:0046339) | 4.34185965 |
30 | plasma lipoprotein particle assembly (GO:0034377) | 4.30681995 |
31 | nitrogen cycle metabolic process (GO:0071941) | 4.26459918 |
32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.17618500 |
33 | glucocorticoid biosynthetic process (GO:0006704) | 4.13883087 |
34 | carnitine metabolic process (GO:0009437) | 4.02500679 |
35 | * drug transport (GO:0015893) | 3.99974241 |
36 | protein-lipid complex assembly (GO:0065005) | 3.94842048 |
37 | regulation of systemic arterial blood pressure (GO:0003073) | 3.93074918 |
38 | fructose metabolic process (GO:0006000) | 3.91995224 |
39 | bile acid metabolic process (GO:0008206) | 3.89490331 |
40 | flavonoid metabolic process (GO:0009812) | 3.86165236 |
41 | protein hydroxylation (GO:0018126) | 3.83273550 |
42 | protein-lipid complex remodeling (GO:0034368) | 3.81320603 |
43 | macromolecular complex remodeling (GO:0034367) | 3.81320603 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.81320603 |
45 | omega-hydroxylase P450 pathway (GO:0097267) | 3.75864547 |
46 | lipoprotein metabolic process (GO:0042157) | 3.71659604 |
47 | low-density lipoprotein particle remodeling (GO:0034374) | 3.68538491 |
48 | phospholipid efflux (GO:0033700) | 3.66181386 |
49 | regulation of cholesterol homeostasis (GO:2000188) | 3.65953295 |
50 | positive regulation of lipid catabolic process (GO:0050996) | 3.65857743 |
51 | high-density lipoprotein particle remodeling (GO:0034375) | 3.58223891 |
52 | cholesterol efflux (GO:0033344) | 3.56991418 |
53 | amino-acid betaine metabolic process (GO:0006577) | 3.56778608 |
54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.52593922 |
55 | heme transport (GO:0015886) | 3.51298634 |
56 | detection of calcium ion (GO:0005513) | 3.47253608 |
57 | plasma lipoprotein particle organization (GO:0071827) | 3.46697166 |
58 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45203550 |
59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45203550 |
60 | intestinal cholesterol absorption (GO:0030299) | 3.44636320 |
61 | alkaloid metabolic process (GO:0009820) | 3.43839818 |
62 | peptide hormone processing (GO:0016486) | 3.42082860 |
63 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.37021974 |
64 | urate metabolic process (GO:0046415) | 3.36030915 |
65 | regulation of protein activation cascade (GO:2000257) | 3.35473851 |
66 | macroautophagy (GO:0016236) | 3.33001504 |
67 | protein-lipid complex subunit organization (GO:0071825) | 3.32238094 |
68 | reverse cholesterol transport (GO:0043691) | 3.31478551 |
69 | ethanol oxidation (GO:0006069) | 3.30994922 |
70 | regulation of complement activation (GO:0030449) | 3.25184262 |
71 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.25120614 |
72 | glucocorticoid metabolic process (GO:0008211) | 3.23732264 |
73 | phenylpropanoid metabolic process (GO:0009698) | 3.22009596 |
74 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.18124797 |
75 | cholesterol homeostasis (GO:0042632) | 3.16829458 |
76 | cellular response to nitric oxide (GO:0071732) | 3.16316175 |
77 | negative regulation of cholesterol transport (GO:0032375) | 3.15605803 |
78 | negative regulation of sterol transport (GO:0032372) | 3.15605803 |
79 | sterol homeostasis (GO:0055092) | 3.12208675 |
80 | actin filament depolymerization (GO:0030042) | 3.11305526 |
81 | glycolipid catabolic process (GO:0019377) | 3.07374266 |
82 | fat-soluble vitamin metabolic process (GO:0006775) | 3.06328283 |
83 | regulation of cellular extravasation (GO:0002691) | 3.02109632 |
84 | glycosphingolipid catabolic process (GO:0046479) | 3.02004036 |
85 | vitamin transport (GO:0051180) | 3.02000456 |
86 | peptide catabolic process (GO:0043171) | 2.99800055 |
87 | regulation of cholesterol metabolic process (GO:0090181) | 2.99513670 |
88 | drinking behavior (GO:0042756) | 2.99242346 |
89 | complement activation, alternative pathway (GO:0006957) | 2.97036477 |
90 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.94297283 |
91 | fat-soluble vitamin catabolic process (GO:0042363) | 2.94200992 |
92 | vitamin catabolic process (GO:0009111) | 2.94200992 |
93 | cellular response to prostaglandin stimulus (GO:0071379) | 2.94022336 |
94 | digestion (GO:0007586) | 2.90638577 |
95 | arginine metabolic process (GO:0006525) | 2.88148726 |
96 | glycosylceramide metabolic process (GO:0006677) | 2.87401698 |
97 | response to nitric oxide (GO:0071731) | 2.87335084 |
98 | positive regulation of steroid metabolic process (GO:0045940) | 2.87277801 |
99 | vitamin transmembrane transport (GO:0035461) | 2.85308494 |
100 | embryonic process involved in female pregnancy (GO:0060136) | 2.84985582 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.75770741 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.68843048 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59131198 |
4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.49664775 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48184793 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39167817 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.30932416 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.12768225 |
9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.90707170 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79251512 |
11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.73642902 |
12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.65775662 |
13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.43187799 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.29274013 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25836051 |
16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.20243031 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16071978 |
18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16034567 |
19 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.12458121 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03524302 |
21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.01247342 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95115821 |
23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.90075710 |
24 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89013750 |
25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.87181536 |
26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81282557 |
27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79516582 |
28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.73144316 |
29 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.61914016 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61778234 |
31 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.59548144 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58937586 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56203808 |
34 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49541408 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43603109 |
36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43234314 |
37 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.40792723 |
38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38926101 |
39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34933692 |
40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30424596 |
41 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30277898 |
42 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.29587104 |
43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27092776 |
44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26870957 |
45 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25943858 |
46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24916200 |
47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24710660 |
48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24273883 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22370119 |
50 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19356518 |
51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16833516 |
52 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.16431077 |
53 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16185429 |
54 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12911533 |
55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12670253 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12661637 |
57 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.11903464 |
58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08722225 |
59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05098230 |
60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03543601 |
61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03285600 |
62 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02164359 |
63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99771268 |
64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98335260 |
65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97141427 |
66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95082281 |
67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91615171 |
68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91562032 |
69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90670989 |
70 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90670989 |
71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90610718 |
72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90407309 |
73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89567396 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89064542 |
75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88783377 |
76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88066765 |
77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87821599 |
78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87473928 |
79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86641978 |
80 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86405960 |
81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.84973490 |
82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82042783 |
83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81257591 |
84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80110518 |
85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79761542 |
86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78512764 |
87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77088160 |
88 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77008553 |
89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75525388 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74798465 |
91 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.73694416 |
92 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72654337 |
93 | * P300_27268052_Chip-Seq_Bcells_Human | 0.72254153 |
94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72167878 |
95 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.71667468 |
96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71256636 |
97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71054762 |
98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.70835592 |
99 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.70571710 |
100 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69185227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 6.59234666 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.40855544 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.86154678 |
4 | MP0002138_abnormal_hepatobiliary_system | 4.43976000 |
5 | MP0001666_abnormal_nutrient_absorption | 4.03386051 |
6 | MP0005365_abnormal_bile_salt | 3.87134726 |
7 | MP0003868_abnormal_feces_composition | 3.56059981 |
8 | MP0000516_abnormal_urinary_system | 3.45144882 |
9 | MP0005367_renal/urinary_system_phenotyp | 3.45144882 |
10 | MP0003183_abnormal_peptide_metabolism | 3.11686138 |
11 | MP0003252_abnormal_bile_duct | 3.09852376 |
12 | MP0010307_abnormal_tumor_latency | 3.08579536 |
13 | MP0009840_abnormal_foam_cell | 2.95419275 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.70900500 |
15 | MP0000538_abnormal_urinary_bladder | 2.61406355 |
16 | MP0005409_darkened_coat_color | 2.28306173 |
17 | MP0010329_abnormal_lipoprotein_level | 2.11903635 |
18 | MP0004147_increased_porphyrin_level | 2.03717842 |
19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02694492 |
20 | MP0004264_abnormal_extraembryonic_tissu | 1.95010967 |
21 | MP0005332_abnormal_amino_acid | 1.77100370 |
22 | MP0002009_preneoplasia | 1.68320820 |
23 | MP0001188_hyperpigmentation | 1.67255503 |
24 | MP0000858_altered_metastatic_potential | 1.59852827 |
25 | MP0010352_gastrointestinal_tract_polyps | 1.56308278 |
26 | MP0010234_abnormal_vibrissa_follicle | 1.48633778 |
27 | MP0002876_abnormal_thyroid_physiology | 1.46853857 |
28 | MP0010155_abnormal_intestine_physiology | 1.46637503 |
29 | MP0003866_abnormal_defecation | 1.41194946 |
30 | MP0009379_abnormal_foot_pigmentation | 1.41148621 |
31 | MP0002877_abnormal_melanocyte_morpholog | 1.39965327 |
32 | MP0009643_abnormal_urine_homeostasis | 1.37408936 |
33 | MP0002166_altered_tumor_susceptibility | 1.36233463 |
34 | MP0001765_abnormal_ion_homeostasis | 1.31434709 |
35 | MP0000609_abnormal_liver_physiology | 1.30516983 |
36 | MP0004484_altered_response_of | 1.28023947 |
37 | MP0001664_abnormal_digestion | 1.26391697 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.25168004 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.16018059 |
40 | MP0009697_abnormal_copulation | 1.13651579 |
41 | MP0003879_abnormal_hair_cell | 1.08806775 |
42 | MP0003195_calcinosis | 1.06170401 |
43 | MP0000477_abnormal_intestine_morphology | 1.01940150 |
44 | MP0000013_abnormal_adipose_tissue | 1.01490944 |
45 | MP0005636_abnormal_mineral_homeostasis | 1.00487177 |
46 | MP0005670_abnormal_white_adipose | 0.97929838 |
47 | MP0003300_gastrointestinal_ulcer | 0.95053472 |
48 | MP0001764_abnormal_homeostasis | 0.94799999 |
49 | MP0004043_abnormal_pH_regulation | 0.91430330 |
50 | MP0002006_tumorigenesis | 0.87228940 |
51 | MP0003191_abnormal_cellular_cholesterol | 0.83968119 |
52 | MP0005319_abnormal_enzyme/_coenzyme | 0.81514263 |
53 | MP0002971_abnormal_brown_adipose | 0.81380464 |
54 | MP0002909_abnormal_adrenal_gland | 0.80982377 |
55 | MP0001873_stomach_inflammation | 0.80953800 |
56 | MP0005451_abnormal_body_composition | 0.80951089 |
57 | MP0002136_abnormal_kidney_physiology | 0.78768567 |
58 | MP0010678_abnormal_skin_adnexa | 0.78719989 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78265244 |
60 | MP0005166_decreased_susceptibility_to | 0.76983379 |
61 | MP0000490_abnormal_crypts_of | 0.76407132 |
62 | MP0000465_gastrointestinal_hemorrhage | 0.72604696 |
63 | MP0003329_amyloid_beta_deposits | 0.70820666 |
64 | MP0003283_abnormal_digestive_organ | 0.67571838 |
65 | MP0008469_abnormal_protein_level | 0.67486713 |
66 | MP0000604_amyloidosis | 0.66553304 |
67 | MP0003763_abnormal_thymus_physiology | 0.66323581 |
68 | MP0000383_abnormal_hair_follicle | 0.66016681 |
69 | MP0001348_abnormal_lacrimal_gland | 0.65912037 |
70 | MP0005448_abnormal_energy_balance | 0.65839779 |
71 | MP0005464_abnormal_platelet_physiology | 0.65455027 |
72 | MP0009642_abnormal_blood_homeostasis | 0.65451339 |
73 | MP0000462_abnormal_digestive_system | 0.64764795 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 0.64371181 |
75 | MP0004215_abnormal_myocardial_fiber | 0.61786933 |
76 | MP0005666_abnormal_adipose_tissue | 0.61208229 |
77 | MP0004782_abnormal_surfactant_physiolog | 0.60901959 |
78 | MP0001756_abnormal_urination | 0.59510663 |
79 | MP0001501_abnormal_sleep_pattern | 0.58337686 |
80 | MP0001661_extended_life_span | 0.58216493 |
81 | MP0001845_abnormal_inflammatory_respons | 0.57583614 |
82 | MP0003950_abnormal_plasma_membrane | 0.57407002 |
83 | MP0002822_catalepsy | 0.57185469 |
84 | MP0000598_abnormal_liver_morphology | 0.53399817 |
85 | MP0000249_abnormal_blood_vessel | 0.52922821 |
86 | MP0005535_abnormal_body_temperature | 0.52694608 |
87 | MP0001835_abnormal_antigen_presentation | 0.51878931 |
88 | MP0002078_abnormal_glucose_homeostasis | 0.50100509 |
89 | MP0009785_altered_susceptibility_to | 0.49574707 |
90 | MP0003953_abnormal_hormone_level | 0.49418464 |
91 | MP0005671_abnormal_response_to | 0.46740143 |
92 | MP0004947_skin_inflammation | 0.46102861 |
93 | MP0000230_abnormal_systemic_arterial | 0.44254199 |
94 | MP0005334_abnormal_fat_pad | 0.43943107 |
95 | MP0003724_increased_susceptibility_to | 0.43458660 |
96 | MP0003436_decreased_susceptibility_to | 0.42169022 |
97 | MP0004858_abnormal_nervous_system | 0.42085199 |
98 | MP0002396_abnormal_hematopoietic_system | 0.40993803 |
99 | MP0009333_abnormal_splenocyte_physiolog | 0.40649683 |
100 | MP0001191_abnormal_skin_condition | 0.39895011 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.98355305 |
2 | Hypobetalipoproteinemia (HP:0003563) | 6.68188653 |
3 | Abnormality of proline metabolism (HP:0010907) | 6.03676565 |
4 | Hydroxyprolinuria (HP:0003080) | 6.03676565 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61080328 |
6 | Facial shape deformation (HP:0011334) | 4.80565875 |
7 | Potter facies (HP:0002009) | 4.80565875 |
8 | Fat malabsorption (HP:0002630) | 4.40953662 |
9 | Acanthocytosis (HP:0001927) | 4.27394691 |
10 | Xanthomatosis (HP:0000991) | 4.17393828 |
11 | Complement deficiency (HP:0004431) | 4.02939115 |
12 | Malnutrition (HP:0004395) | 3.93877269 |
13 | Abnormality of complement system (HP:0005339) | 3.80704710 |
14 | Chronic diarrhea (HP:0002028) | 3.71132441 |
15 | Widely patent fontanelles and sutures (HP:0004492) | 3.68974298 |
16 | Systemic lupus erythematosus (HP:0002725) | 3.63954168 |
17 | Deep venous thrombosis (HP:0002625) | 3.57646110 |
18 | Intrahepatic cholestasis (HP:0001406) | 3.55567331 |
19 | Hypolipoproteinemia (HP:0010981) | 3.39873655 |
20 | Abnormality of vitamin metabolism (HP:0100508) | 3.39218694 |
21 | Abnormality of vitamin B metabolism (HP:0004340) | 3.18055006 |
22 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.17629269 |
23 | Decreased circulating renin level (HP:0003351) | 3.12872359 |
24 | Ileus (HP:0002595) | 3.05513508 |
25 | Glomerulonephritis (HP:0000099) | 2.95911586 |
26 | Glycosuria (HP:0003076) | 2.94698134 |
27 | Abnormality of urine glucose concentration (HP:0011016) | 2.94698134 |
28 | Pigmentary retinal degeneration (HP:0001146) | 2.92319378 |
29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.91369528 |
30 | Wide cranial sutures (HP:0010537) | 2.91189128 |
31 | Abnormality of the common coagulation pathway (HP:0010990) | 2.88433396 |
32 | Steatorrhea (HP:0002570) | 2.86939810 |
33 | Hemorrhage of the eye (HP:0011885) | 2.82104095 |
34 | Confusion (HP:0001289) | 2.80857527 |
35 | Metabolic alkalosis (HP:0200114) | 2.80677575 |
36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.75864440 |
37 | Alkalosis (HP:0001948) | 2.73620359 |
38 | Prolonged partial thromboplastin time (HP:0003645) | 2.69554974 |
39 | Epidermoid cyst (HP:0200040) | 2.59768815 |
40 | Hypophosphatemia (HP:0002148) | 2.55136494 |
41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54808684 |
42 | Hyperammonemia (HP:0001987) | 2.53782523 |
43 | Hyperphosphaturia (HP:0003109) | 2.50033264 |
44 | Nephrolithiasis (HP:0000787) | 2.48155134 |
45 | Hypophosphatemic rickets (HP:0004912) | 2.47244472 |
46 | Hyperglycinuria (HP:0003108) | 2.42255187 |
47 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.41467719 |
48 | Villous atrophy (HP:0011473) | 2.41467719 |
49 | Nephritis (HP:0000123) | 2.38834056 |
50 | Rickets (HP:0002748) | 2.37934197 |
51 | Abnormal urine phosphate concentration (HP:0012599) | 2.37533199 |
52 | Vascular calcification (HP:0004934) | 2.37150560 |
53 | Elevated alkaline phosphatase (HP:0003155) | 2.34824045 |
54 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.33690617 |
55 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.32431566 |
56 | Hypotension (HP:0002615) | 2.30126110 |
57 | Abnormality of renin-angiotensin system (HP:0000847) | 2.28023579 |
58 | Proximal tubulopathy (HP:0000114) | 2.26523769 |
59 | Focal segmental glomerulosclerosis (HP:0000097) | 2.22805900 |
60 | Abnormality of glycine metabolism (HP:0010895) | 2.20225476 |
61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20225476 |
62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20079262 |
63 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19401456 |
64 | Joint hemorrhage (HP:0005261) | 2.14758207 |
65 | Gout (HP:0001997) | 2.14025899 |
66 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.11438435 |
67 | Amyloidosis (HP:0011034) | 2.10898289 |
68 | Abnormal gallbladder physiology (HP:0012438) | 2.10181375 |
69 | Cholecystitis (HP:0001082) | 2.10181375 |
70 | Mitral stenosis (HP:0001718) | 2.08280733 |
71 | Wide nose (HP:0000445) | 2.06657825 |
72 | Pancreatitis (HP:0001733) | 2.05464732 |
73 | Poikilocytosis (HP:0004447) | 2.05267472 |
74 | Joint swelling (HP:0001386) | 2.03388655 |
75 | Hyperlipoproteinemia (HP:0010980) | 2.01812698 |
76 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98440301 |
77 | Abdominal distention (HP:0003270) | 1.97456551 |
78 | Skin nodule (HP:0200036) | 1.97349222 |
79 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96049914 |
80 | Megaloblastic anemia (HP:0001889) | 1.95457036 |
81 | Flat acetabular roof (HP:0003180) | 1.93004875 |
82 | Abnormality of purine metabolism (HP:0004352) | 1.92482823 |
83 | Abnormal tarsal ossification (HP:0008369) | 1.91693292 |
84 | Thin bony cortex (HP:0002753) | 1.90880724 |
85 | Hyperuricemia (HP:0002149) | 1.90333010 |
86 | Increased purine levels (HP:0004368) | 1.90333010 |
87 | Cardiovascular calcification (HP:0011915) | 1.89786233 |
88 | Hyperaldosteronism (HP:0000859) | 1.87855031 |
89 | Prominent nose (HP:0000448) | 1.84315885 |
90 | Growth hormone excess (HP:0000845) | 1.77195838 |
91 | Generalized aminoaciduria (HP:0002909) | 1.75620345 |
92 | Glomerulosclerosis (HP:0000096) | 1.75392117 |
93 | Nausea (HP:0002018) | 1.70698172 |
94 | Abnormality of carpal bone ossification (HP:0006257) | 1.70299150 |
95 | Metabolic acidosis (HP:0001942) | 1.69322319 |
96 | Hyperparathyroidism (HP:0000843) | 1.69014968 |
97 | Enlarged kidneys (HP:0000105) | 1.67268099 |
98 | Pheochromocytoma (HP:0002666) | 1.66057784 |
99 | Late onset (HP:0003584) | 1.66031561 |
100 | Alveolar cell carcinoma (HP:0006519) | 1.65681982 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 5.03561269 |
2 | ERBB4 | 4.48174821 |
3 | ICK | 4.02748372 |
4 | MAP3K14 | 3.84326437 |
5 | TAOK3 | 2.82436364 |
6 | TXK | 2.60056527 |
7 | AKT3 | 2.55026492 |
8 | RIPK1 | 2.37594775 |
9 | FGFR4 | 2.28496927 |
10 | PRKG2 | 2.20285878 |
11 | NTRK1 | 2.08740650 |
12 | MET | 2.07727480 |
13 | CAMKK2 | 2.00514952 |
14 | ERN1 | 2.00241058 |
15 | MST1R | 1.95778863 |
16 | EPHA2 | 1.89217635 |
17 | JAK1 | 1.82953545 |
18 | FGFR3 | 1.77420234 |
19 | GRK6 | 1.72518911 |
20 | SIK3 | 1.69209470 |
21 | STK39 | 1.56942168 |
22 | CDK12 | 1.55985315 |
23 | TBK1 | 1.50125163 |
24 | LATS1 | 1.48784611 |
25 | MAP3K10 | 1.43066604 |
26 | MAP2K2 | 1.40383318 |
27 | PDGFRA | 1.39517415 |
28 | MAPK11 | 1.37489012 |
29 | TRPM7 | 1.35245344 |
30 | PTK2 | 1.33187559 |
31 | PTK6 | 1.28094513 |
32 | RET | 1.26276089 |
33 | BRSK2 | 1.20061619 |
34 | FLT3 | 1.10400448 |
35 | TYK2 | 1.08074935 |
36 | JAK3 | 1.05116522 |
37 | MAP3K2 | 1.04566663 |
38 | MAP3K6 | 1.03031437 |
39 | MELK | 1.02860729 |
40 | PDPK1 | 1.01460823 |
41 | OXSR1 | 0.99785240 |
42 | PDK1 | 0.99681876 |
43 | ZAP70 | 0.89545046 |
44 | MST4 | 0.88742078 |
45 | PRKAA2 | 0.86255627 |
46 | PIK3CA | 0.85690707 |
47 | TESK2 | 0.83789050 |
48 | BMPR2 | 0.83740439 |
49 | EPHB1 | 0.83427694 |
50 | PDGFRB | 0.79394564 |
51 | FGR | 0.76891428 |
52 | PINK1 | 0.76389280 |
53 | MAP3K12 | 0.73439909 |
54 | KDR | 0.72771740 |
55 | YES1 | 0.68237915 |
56 | MAP3K1 | 0.67841271 |
57 | MATK | 0.67610503 |
58 | STK38 | 0.65320770 |
59 | CAMKK1 | 0.64183950 |
60 | ITK | 0.63782665 |
61 | FRK | 0.61481163 |
62 | BRD4 | 0.57528713 |
63 | LCK | 0.56252871 |
64 | EPHA3 | 0.55747873 |
65 | IGF1R | 0.55156584 |
66 | IKBKE | 0.55082970 |
67 | CSF1R | 0.55033048 |
68 | SGK3 | 0.50444098 |
69 | NLK | 0.47758414 |
70 | MAP4K2 | 0.47019875 |
71 | MAP3K7 | 0.45729078 |
72 | MAP4K1 | 0.43792081 |
73 | DYRK1B | 0.42089220 |
74 | IKBKB | 0.41013959 |
75 | MAP3K5 | 0.38667911 |
76 | ATR | 0.38525705 |
77 | TRIB3 | 0.38035989 |
78 | PIM1 | 0.37880485 |
79 | CSK | 0.37714364 |
80 | CAMK2B | 0.37363969 |
81 | IRAK3 | 0.36482355 |
82 | * PRKACG | 0.36022021 |
83 | PRPF4B | 0.35703765 |
84 | NEK2 | 0.35007943 |
85 | CDK9 | 0.34635357 |
86 | SMG1 | 0.33364404 |
87 | STK3 | 0.32746445 |
88 | EEF2K | 0.32707961 |
89 | MAP3K4 | 0.32192812 |
90 | MARK3 | 0.31923729 |
91 | MYLK | 0.31122038 |
92 | FYN | 0.29964198 |
93 | PRKCQ | 0.29405002 |
94 | SRC | 0.29063206 |
95 | SIK2 | 0.27853000 |
96 | MAP3K8 | 0.27793477 |
97 | LMTK2 | 0.27353772 |
98 | SYK | 0.26212189 |
99 | STK10 | 0.25117493 |
100 | AKT2 | 0.24948006 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.11565299 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.52023486 |
3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.51994920 |
4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.31676662 |
5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.01539187 |
6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.95690119 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.77120860 |
8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.51841659 |
9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.50155879 |
10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.49889530 |
11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.37950209 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.34313633 |
13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.33117091 |
14 | * Bile secretion_Homo sapiens_hsa04976 | 2.32049310 |
15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29534446 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.20046275 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.11850959 |
18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81532883 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77354554 |
20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76713017 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70929688 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70204339 |
23 | Mineral absorption_Homo sapiens_hsa04978 | 1.66676152 |
24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.66567090 |
25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.65913931 |
26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54582642 |
27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54238006 |
28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53642332 |
29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52886275 |
30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.52740748 |
31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51875644 |
32 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.46939469 |
33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43171377 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33479354 |
35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33345488 |
36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15826103 |
37 | * ABC transporters_Homo sapiens_hsa02010 | 1.10670544 |
38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10640905 |
39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06495599 |
40 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99924077 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95869276 |
42 | Peroxisome_Homo sapiens_hsa04146 | 0.84753955 |
43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84020487 |
44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81047968 |
45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79419217 |
46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73406068 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 0.67261743 |
48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64696219 |
49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63857351 |
50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63171189 |
51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57654770 |
52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56836163 |
53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56583555 |
54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54922114 |
55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54921932 |
56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53857358 |
57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52466710 |
58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52057828 |
59 | Renin secretion_Homo sapiens_hsa04924 | 0.50813355 |
60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47972371 |
61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47079753 |
62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44302897 |
63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42859380 |
64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42577590 |
65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41241537 |
66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40184349 |
67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36654043 |
68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35805041 |
69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34668120 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32838850 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.28580448 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27335641 |
73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25919597 |
74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25474496 |
75 | Pertussis_Homo sapiens_hsa05133 | 0.25391958 |
76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23927648 |
77 | Hepatitis C_Homo sapiens_hsa05160 | 0.22978563 |
78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.20710422 |
79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19947684 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.19858971 |
81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19133243 |
82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18979975 |
83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18847579 |
84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17237803 |
85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17139176 |
86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14341247 |
87 | Tight junction_Homo sapiens_hsa04530 | 0.14153729 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.14124377 |
89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12767179 |
90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.12747240 |
91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12642226 |
92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11515578 |
93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.11354150 |
94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10559300 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10439682 |
96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09605574 |
97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.09348704 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08111239 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.07984579 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07545880 |